Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1997 Mar;76(3):278–282. doi: 10.1136/adc.76.3.278

ΔF508 in cystic fibrosis: willing but not able

K Southern 1
PMCID: PMC1717108  PMID: 9135274

Full Text

The Full Text of this article is available as a PDF (197.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson M. P., Gregory R. J., Thompson S., Souza D. W., Paul S., Mulligan R. C., Smith A. E., Welsh M. J. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science. 1991 Jul 12;253(5016):202–205. doi: 10.1126/science.1712984. [DOI] [PubMed] [Google Scholar]
  2. Bear C. E., Li C. H., Kartner N., Bridges R. J., Jensen T. J., Ramjeesingh M., Riordan J. R. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 1992 Feb 21;68(4):809–818. doi: 10.1016/0092-8674(92)90155-6. [DOI] [PubMed] [Google Scholar]
  3. Beckmann R. P., Mizzen L. E., Welch W. J. Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly. Science. 1990 May 18;248(4957):850–854. doi: 10.1126/science.2188360. [DOI] [PubMed] [Google Scholar]
  4. Bowler I. M., Estlin E. J., Littlewood J. M. Cystic fibrosis in Asians. Arch Dis Child. 1993 Jan;68(1):120–122. doi: 10.1136/adc.68.1.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burgoyne R. D. Trimeric G proteins in Golgi transport. Trends Biochem Sci. 1992 Mar;17(3):87–88. [PubMed] [Google Scholar]
  6. Cheng S. H., Gregory R. J., Marshall J., Paul S., Souza D. W., White G. A., O'Riordan C. R., Smith A. E. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 1990 Nov 16;63(4):827–834. doi: 10.1016/0092-8674(90)90148-8. [DOI] [PubMed] [Google Scholar]
  7. Colledge W. H., Abella B. S., Southern K. W., Ratcliff R., Jiang C., Cheng S. H., MacVinish L. J., Anderson J. R., Cuthbert A. W., Evans M. J. Generation and characterization of a delta F508 cystic fibrosis mouse model. Nat Genet. 1995 Aug;10(4):445–452. doi: 10.1038/ng0895-445. [DOI] [PubMed] [Google Scholar]
  8. Cuthbert A. W., Halstead J., Ratcliff R., Colledge W. H., Evans M. J. The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J Physiol. 1995 Jan 15;482(Pt 2):449–454. doi: 10.1113/jphysiol.1995.sp020531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dalemans W., Barbry P., Champigny G., Jallat S., Dott K., Dreyer D., Crystal R. G., Pavirani A., Lecocq J. P., Lazdunski M. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature. 1991 Dec 19;354(6354):526–528. doi: 10.1038/354526a0. [DOI] [PubMed] [Google Scholar]
  10. Denning G. M., Anderson M. P., Amara J. F., Marshall J., Smith A. E., Welsh M. J. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature. 1992 Aug 27;358(6389):761–764. doi: 10.1038/358761a0. [DOI] [PubMed] [Google Scholar]
  11. Drumm M. L., Pope H. A., Cliff W. H., Rommens J. M., Marvin S. A., Tsui L. C., Collins F. S., Frizzell R. A., Wilson J. M. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell. 1990 Sep 21;62(6):1227–1233. doi: 10.1016/0092-8674(90)90398-x. [DOI] [PubMed] [Google Scholar]
  12. Drumm M. L., Wilkinson D. J., Smit L. S., Worrell R. T., Strong T. V., Frizzell R. A., Dawson D. C., Collins F. S. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science. 1991 Dec 20;254(5039):1797–1799. doi: 10.1126/science.1722350. [DOI] [PubMed] [Google Scholar]
  13. Egan M. E., Schwiebert E. M., Guggino W. B. Differential expression of ORCC and CFTR induced by low temperature in CF airway epithelial cells. Am J Physiol. 1995 Jan;268(1 Pt 1):C243–C251. doi: 10.1152/ajpcell.1995.268.1.C243. [DOI] [PubMed] [Google Scholar]
  14. Eidelman O., Guay-Broder C., van Galen P. J., Jacobson K. A., Fox C., Turner R. J., Cabantchik Z. I., Pollard H. B. A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5562–5566. doi: 10.1073/pnas.89.12.5562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gabriel S. E., Brigman K. N., Koller B. H., Boucher R. C., Stutts M. J. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science. 1994 Oct 7;266(5182):107–109. doi: 10.1126/science.7524148. [DOI] [PubMed] [Google Scholar]
  16. Gething M. J., Sambrook J. Protein folding in the cell. Nature. 1992 Jan 2;355(6355):33–45. doi: 10.1038/355033a0. [DOI] [PubMed] [Google Scholar]
  17. Guay-Broder C., Jacobson K. A., Barnoy S., Cabantchik Z. I., Guggino W. B., Zeitlin P. L., Turner R. J., Vergara L., Eidelman O., Pollard H. B. A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation. Biochemistry. 1995 Jul 18;34(28):9079–9087. doi: 10.1021/bi00028a017. [DOI] [PubMed] [Google Scholar]
  18. Guggino S. E. Gates of Janus: cystic fibrosis and diarrhea. Trends Microbiol. 1994 Mar;2(3):91–94. doi: 10.1016/0966-842x(94)90541-x. [DOI] [PubMed] [Google Scholar]
  19. Hartman J., Huang Z., Rado T. A., Peng S., Jilling T., Muccio D. D., Sorscher E. J. Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product. J Biol Chem. 1992 Apr 5;267(10):6455–6458. [PubMed] [Google Scholar]
  20. Jackson M. R., Cohen-Doyle M. F., Peterson P. A., Williams D. B. Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). Science. 1994 Jan 21;263(5145):384–387. doi: 10.1126/science.8278813. [DOI] [PubMed] [Google Scholar]
  21. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  22. Knowles M. R., Hohneker K. W., Zhou Z., Olsen J. C., Noah T. L., Hu P. C., Leigh M. W., Engelhardt J. F., Edwards L. J., Jones K. R. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med. 1995 Sep 28;333(13):823–831. doi: 10.1056/NEJM199509283331302. [DOI] [PubMed] [Google Scholar]
  23. Li C., Ramjeesingh M., Reyes E., Jensen T., Chang X., Rommens J. M., Bear C. E. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. Nat Genet. 1993 Apr;3(4):311–316. doi: 10.1038/ng0493-311. [DOI] [PubMed] [Google Scholar]
  24. Lukacs G. L., Chang X. B., Bear C., Kartner N., Mohamed A., Riordan J. R., Grinstein S. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem. 1993 Oct 15;268(29):21592–21598. [PubMed] [Google Scholar]
  25. Lukacs G. L., Mohamed A., Kartner N., Chang X. B., Riordan J. R., Grinstein S. Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 1994 Dec 15;13(24):6076–6086. doi: 10.1002/j.1460-2075.1994.tb06954.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Machamer C. E., Rose J. K. Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature-sensitive intracellular transport and are subject to aberrant intermolecular disulfide bonding. J Biol Chem. 1988 Apr 25;263(12):5955–5960. [PubMed] [Google Scholar]
  27. Mennie M., Gilfillan A., Brock D. J., Liston W. A. Heterozygotes for the delta F508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med. 1995 Oct;1(10):978–979. doi: 10.1038/nm1095-978b. [DOI] [PubMed] [Google Scholar]
  28. Morral N., Bertranpetit J., Estivill X., Nunes V., Casals T., Giménez J., Reis A., Varon-Mateeva R., Macek M., Jr, Kalaydjieva L. The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nat Genet. 1994 Jun;7(2):169–175. doi: 10.1038/ng0694-169. [DOI] [PubMed] [Google Scholar]
  29. Ou W. J., Cameron P. H., Thomas D. Y., Bergeron J. J. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature. 1993 Aug 26;364(6440):771–776. doi: 10.1038/364771a0. [DOI] [PubMed] [Google Scholar]
  30. Pasyk E. A., Foskett J. K. Mutant (delta F508) cystic fibrosis transmembrane conductance regulator Cl- channel is functional when retained in endoplasmic reticulum of mammalian cells. J Biol Chem. 1995 May 26;270(21):12347–12350. doi: 10.1074/jbc.270.21.12347. [DOI] [PubMed] [Google Scholar]
  31. Pind S., Riordan J. R., Williams D. B. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem. 1994 Apr 29;269(17):12784–12788. [PubMed] [Google Scholar]
  32. Rich D. P., Anderson M. P., Gregory R. J., Cheng S. H., Paul S., Jefferson D. M., McCann J. D., Klinger K. W., Smith A. E., Welsh M. J. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature. 1990 Sep 27;347(6291):358–363. doi: 10.1038/347358a0. [DOI] [PubMed] [Google Scholar]
  33. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  34. Roberts L. The race for the cystic fibrosis gene. Science. 1988 Apr 8;240(4849):141–144. doi: 10.1126/science.3281257. [DOI] [PubMed] [Google Scholar]
  35. Romeo G., Devoto M., Galietta L. J. Why is the cystic fibrosis gene so frequent? Hum Genet. 1989 Dec;84(1):1–5. doi: 10.1007/BF00210660. [DOI] [PubMed] [Google Scholar]
  36. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  37. Sato S., Ward C. L., Krouse M. E., Wine J. J., Kopito R. R. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem. 1996 Jan 12;271(2):635–638. doi: 10.1074/jbc.271.2.635. [DOI] [PubMed] [Google Scholar]
  38. Schroeder S. A., Gaughan D. M., Swift M. Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis. Nat Med. 1995 Jul;1(7):703–705. doi: 10.1038/nm0795-703. [DOI] [PubMed] [Google Scholar]
  39. Schwiebert E. M., Egan M. E., Hwang T. H., Fulmer S. B., Allen S. S., Cutting G. R., Guggino W. B. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell. 1995 Jun 30;81(7):1063–1073. doi: 10.1016/s0092-8674(05)80011-x. [DOI] [PubMed] [Google Scholar]
  40. Schwiebert E. M., Gesek F., Ercolani L., Wjasow C., Gruenert D. C., Karlson K., Stanton B. A. Heterotrimeric G proteins, vesicle trafficking, and CFTR Cl- channels. Am J Physiol. 1994 Jul;267(1 Pt 1):C272–C281. doi: 10.1152/ajpcell.1994.267.1.C272. [DOI] [PubMed] [Google Scholar]
  41. Serre J. L., Simon-Bouy B., Mornet E., Jaume-Roig B., Balassopoulou A., Schwartz M., Taillandier A., Boué J., Boué A. Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics. Hum Genet. 1990 Apr;84(5):449–454. doi: 10.1007/BF00195818. [DOI] [PubMed] [Google Scholar]
  42. Sferra T. J., Collins F. S. The molecular biology of cystic fibrosis. Annu Rev Med. 1993;44:133–144. doi: 10.1146/annurev.me.44.020193.001025. [DOI] [PubMed] [Google Scholar]
  43. Stutts M. J., Canessa C. M., Olsen J. C., Hamrick M., Cohn J. A., Rossier B. C., Boucher R. C. CFTR as a cAMP-dependent regulator of sodium channels. Science. 1995 Aug 11;269(5225):847–850. doi: 10.1126/science.7543698. [DOI] [PubMed] [Google Scholar]
  44. Thomas P. J., Shenbagamurthi P., Ysern X., Pedersen P. L. Cystic fibrosis transmembrane conductance regulator: nucleotide binding to a synthetic peptide. Science. 1991 Feb 1;251(4993):555–557. doi: 10.1126/science.1703660. [DOI] [PubMed] [Google Scholar]
  45. Tsui L. C., Buchwald M., Barker D., Braman J. C., Knowlton R., Schumm J. W., Eiberg H., Mohr J., Kennedy D., Plavsic N. Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science. 1985 Nov 29;230(4729):1054–1057. doi: 10.1126/science.2997931. [DOI] [PubMed] [Google Scholar]
  46. Ward C. L., Kopito R. R. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J Biol Chem. 1994 Oct 14;269(41):25710–25718. [PubMed] [Google Scholar]
  47. Yang Y., Janich S., Cohn J. A., Wilson J. M. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9480–9484. doi: 10.1073/pnas.90.20.9480. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES